FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

9803311000001102: Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31594501000001116 Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41000701000001119 Spironolactone 50mg tablets (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Is a Product containing precisely spironolactone 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) 28 tablet 2 x 14 tablets Is pack of False Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Inferred relationship Existential restriction modifier
Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) 28 tablet 2 x 14 tablets Has AMP True Spironolactone 50mg tablets (Almus Pharmaceutical Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start